| Date Filed | Type | Description |
| 10/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 19,700 shares
@ $10.0266, valued at
$197.5k
Sold 19,956 shares
@ $11.0046, valued at
$219.6k
Exercised 19,700 options to buy
@ $3.55, valued at
$69.9k
Exercised 19,956 options to buy
@ $3.55, valued at
$70.8k
|
|
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/28/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 1,400 shares
@ $10, valued at
$14k
Sold 2,800 shares
@ $10.0081, valued at
$28k
Sold 200 shares
@ $10, valued at
$2k
Exercised 1,400 options to buy
@ $3.55, valued at
$5k
Exercised 2,800 options to buy
@ $3.55, valued at
$9.9k
Exercised 200 options to buy
@ $3.55, valued at
$710 |
|
| 04/24/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 11,678 shares
@ $9.6002, valued at
$112.1k
Sold 16,162 shares
@ $9.4747, valued at
$153.1k
Sold 12,160 shares
@ $9.6405, valued at
$117.2k
Exercised 11,678 options to buy
@ $3.55, valued at
$41.5k
Exercised 16,162 options to buy
@ $3.55, valued at
$57.4k
Exercised 12,160 options to buy
@ $3.55, valued at
$43.2k
|
|
| 03/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/28/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Exercised 40,000 options to buy
@ $1.81, valued at
$72.4k
Exercised 40,000 shares
@ $1.81, valued at
$72.4k
Sold 40,000 shares
@ $9.2973, valued at
$371.9k
|
|
| 08/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/16/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,827 shares
@ $10.41, valued at
$19k
Paid exercise price by delivering 26,090 shares
@ $10.41, valued at
$271.6k
Paid exercise price by delivering 2,610 shares
@ $10.41, valued at
$27.2k
Granted 40,000 options to buy
@ $0
Exercised 3,500 options to buy
@ $0
Exercised 5,000 options to buy
@ $0
Exercised 50,000 options to buy
@ $0 |
|
| 04/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/30/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 840 shares
@ $9.2878, valued at
$7.8k
Sold 9,160 shares
@ $9.2878, valued at
$85.1k
Exercised 840 options to buy
@ $2.49, valued at
$2.1k
Exercised 9,160 options to buy
@ $2.49, valued at
$22.8k
|
|
| 03/21/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $9.0936, valued at
$90.9k
Exercised 10,000 options to buy
@ $2.49, valued at
$24.9k
|
|
| 03/17/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 11,243 options to buy
@ $9.12, valued at
$102.5k
Granted 128,757 options to buy
@ $9.12, valued at
$1.2M
Granted 20,000 options to buy
@ $0 |
|
| 03/08/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 17,594 shares
@ $10.006, valued at
$176k
Sold 2,406 shares
@ $10, valued at
$24.1k
Exercised 17,594 options to buy
@ $2.49, valued at
$43.8k
Exercised 2,406 options to buy
@ $2.49, valued at
$6k
|
|
| 03/01/2016 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $9.9771, valued at
$99.8k
Exercised 10,000 options to buy
@ $2.49, valued at
$24.9k
|
|
|